NPI registry status
Active
2026 NPPES data Rheumatology Physician NPI 1447240239 MD
Verify on CMS → Andy Abril, MD
Rheumatology Physician in Jacksonville, Florida.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 6,377 in Rheumatology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
631
Medicare Part D claims · 197 beneficiaries · Rheumatology Physician avg: 2K
Generic prescribing
83%
generic claims · 17% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
76.2/100
▼ 7 pts below national avg 83.5 · Above neutral
Industry payments
$4.9K
10 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Andy Abril, MD reported a CMS MIPS final score of 76.2/100 - below the 83.5 national average - and filed 631 Medicare Part D claims in 2024.
- 76.2/100
- MIPS score · -7 vs avg
- 631
- Part D claims, 2024
- 83%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Andy Abril, MD
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1447240239), first enumerated 10/24/2005.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 631 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 76.2/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$4.9K in reported industry payments (10 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
Florida statewide board action statistics are published annually — these figures describe aggregate state activity, not Andy Abril, MD's individual license status. Verify directly with the state medical board.
Source: FLDOH annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1447240239 · Rheumatology Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-BELOW · RX-LIGHT · BOOK-THIN · PHOTO-FINISH
- NPI-10 1447240239
- ENUM-LEGACY 2005
- TAX-MID 6K Rheumatology Physician
- MIPS-BELOW 76.2/100
- RX-LIGHT 631
- BOOK-THIN 431 in Florida
- PHOTO-FINISH Vikas Majithia · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Abril · this pro…
Abril · this provider
76.2 MIPS pts
- Vikas Majithia ·…
Vikas Majithia
76.2 MIPS pts
- Andrew Long · near
Andrew Long
76.2 MIPS pts
- John Lavery · near
John Lavery
76.2 MIPS pts
- Michael Maehara …
Michael Maehara
76.3 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Andy Abril, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
76 ≥ 17th percentile 17% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Andy Abril, MD sits
This provider among rheumatology physician peers
Across the 1,970 rheumatology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Andy Abril, MD writes more Part D claims than 17% of them and scores higher on MIPS quality than 19% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one rheumatology physician peer from a representative sample of 60; the gold marker is Andy Abril, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Andy Abril, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Andy Abril, MD?
Below national averagePrimary specialty
Rheumatology Physician
Medicare Part D claims
631 69% vs specialty avg
MIPS final score
76.2/100 7.3 pts vs avg
Specialty distribution in Florida
How Rheumatology Physician compares to other specialties among Florida providers
Medicare quality performance, MIPS
Andy Abril, MD's 2023 MIPS final score plotted against the Rheumatology Physician national average
- MIPS Final Score
- 76.2/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1447240239 |
|---|---|
| Specialty | Rheumatology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 10/24/2005 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
76.2008
Final Score
Measured-score avg: 83.5
69.3395
Quality
51.3298
Cost
100
Promoting Interoperability
Reporting: Group practice
Hospital and facility affiliations
Facilities where Andy Abril, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Mayo Clinic Jacksonville
Jacksonville, FL
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Andy Abril, MD. Source: openpaymentsdata.cms.gov.
Total received
$4.9K
Largest payer
Boehringer Ingelheim Pharmaceuticals, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Florida FLDOH 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 - they are NOT specific to Andy Abril, MD. To verify Andy Abril, MD's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases
FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
Andy Abril, MD - brand share 17.0%
Rheumatology Physician average
17% brand-name claims vs 83% generic, on 631 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
631
Total Claims
$904K
Total Drug Cost
197
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,386.467
- Total Day Supply
- 40,762
- Brand vs Generic
- 17% brand / 83% generic
- Brand Drug Cost
- $882K
- Generic Drug Cost
- $22K
- Opioid Claims
- 19 (3.0% rate)
Patient Demographics
- Average Patient Age
- 71.5 years
- Avg HCC Risk Score
- 1.78
- Gender Split
- 57% female / 43% male
- Age Distribution
- <65: 27, 65-74: 95, 75-84: 59, 85+: 16
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Andy Abril, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Prednisone
Prednisone
144 claims
- Methotrexate
Methotrexate
92 claims
- Hydroxychloroquine…
Hydroxychloroquine Sulfate
62 claims
- Mycophenolate Mofe… 41
Mycophenolate Mofetil
41 claims
- Folic Acid 33
Folic Acid
33 claims
- Methylprednisolone 18
Methylprednisolone
18 claims
- Enbrel Sureclick 16
Enbrel Sureclick
16 claims
- Actemra 13
Actemra
13 claims
| Drug | Claims |
|---|---|
| Prednisone | 144 |
| Methotrexate Methotrexate Sodium | 92 |
| Hydroxychloroquine Sulfate | 62 |
| Mycophenolate Mofetil | 41 |
| Folic Acid | 33 |
| Methylprednisolone | 18 |
| Enbrel Sureclick Etanercept | 16 |
| Actemra Tocilizumab | 13 |
| Rinvoq Upadacitinib | 13 |
| Cimzia (2 Pack) Certolizumab Pegol | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Rheumatology Physician Overview
How Andy Abril, MD fits within the Rheumatology Physician landscape nationally.
6,377
Rheumatology Physician Providers in US
52
States with Rheumatology Physician
2,058
Avg Claims per Provider
Andy Abril, MD's 631 claims are below the specialty average of 2,058.
Nationwide Rheumatology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Abril, both outside Florida so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (76.2 here).
Same NPPES enumeration year (2005)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Rheumatology Physician Providers in Florida
Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as Abril.
One of 431 Rheumatology Physician providers enrolled in Florida, 5 are shown here.
Dr. Katherine Abella
M.D.
Clearwater, FL
Dr. Mohamed Aboyoussef
M.D.
Merritt Island, FL
Dr. Hasan Abualula
MD
Summerfield, FL
Sewar Abuarqob
Gainesville, FL
Dr. Mayra Acosta
MD
Miami, FL
Compare Rheumatology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Andy Abril, MD's specialty? ▼
Andy Abril, MD specializes in Rheumatology Physician and practices in Jacksonville, Florida. Credentials: MD.
How much does Andy Abril, MD prescribe under Medicare Part D? ▼
In 2024, Andy Abril, MD wrote 631 Medicare Part D claims totaling $904K in drug costs for 197 beneficiaries.
What is Andy Abril, MD's Medicare quality score? ▼
Andy Abril, MD has a CMS MIPS Final Score of 76.2/100 (Quality: 69.3, Cost: 51.3). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Andy Abril, MD located? ▼
Andy Abril, MD is located at 4500 SAN PABLO RD S, Jacksonville, FL, 32224. Phone: (904) 953-2000.
What is Andy Abril, MD's NPI number? ▼
Andy Abril, MD's National Provider Identifier (NPI) is 1447240239, issued on 10/24/2005.
Does Andy Abril, MD prescribe more brand-name or generic drugs? ▼
Andy Abril, MD's prescribing is 17% brand-name and 83% generic drugs by claim count, with $882K in brand drug costs.
Does Andy Abril, MD prescribe opioids? ▼
Yes, Andy Abril, MD had 19 opioid claims in 2024 with an opioid prescribing rate of 3.0%.
How many Rheumatology Physician providers are there in the US? ▼
There are 6,377 Rheumatology Physician providers across 52 states in the US. The average Rheumatology Physician provider writes 2,058 Medicare Part D claims per year.
What drugs does Andy Abril, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Andy Abril, MD's most frequently prescribed drugs include Prednisone, Methotrexate, Hydroxychloroquine Sulfate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Andy Abril, MD accept Medicare? ▼
Andy Abril, MD appears in CMS Medicare data with 631 Part D claims and 197 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Andy Abril, MD's credentials? ▼
Andy Abril, MD's NPI is 1447240239 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.